Financials data is unavailable for this security.
View more
Year on year Universe Pharmaceuticals Inc had revenues fall -19.52% from 40.14m to 32.31m, though the company grew net income from a loss of 8.74m to a smaller loss of 6.16m.
Gross margin | 31.93% |
---|---|
Net profit margin | -19.08% |
Operating margin | -10.92% |
Return on assets | -10.92% |
---|---|
Return on equity | -14.34% |
Return on investment | -14.34% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Universe Pharmaceuticals Inc fell by 426.21k. However, the company earned 1.12m from its operations for a Cash Flow Margin of 3.47%. In addition the company used 44.17k on investing activities and also paid 1.39m in financing cash flows.
Cash flow per share | -1.56 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 10.91 |
---|---|
Tangible book value per share | 10.86 |
More ▼
Balance sheet in USDView more
Current ratio | 2.68 |
---|---|
Quick ratio | 2.43 |
Total debt/total equity | 0.1387 |
---|---|
Total debt/total capital | 0.1218 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 29.46%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 29.46 |